HpdMI12465 heterozygosity has no significant effect in the adult locomotor capacity (in negative geotaxis assays) in 18 days old adults and has no obvious effect on the adult brain, as compared to controls.
HpdMI12465/Hpd[+] is an enhancer of abnormal locomotor behavior | adult stage | progressive phenotype of Hsap\APPAβ42.UAS.Tag:SS(rPENK), Scer\GAL4elav-C155
HpdMI12465/Hpd[+] is a non-enhancer of abnormal neuroanatomy | adult stage phenotype of Hsap\APPAβ42.UAS.Tag:SS(rPENK), Scer\GAL4elav-C155
HpdMI12465/Hpd[+] is a non-enhancer of abnormal size | adult stage phenotype of Hsap\APPAβ42.UAS.Tag:SS(rPENK), Scer\GAL4elav-C155
HpdMI12465/Hpd[+] is a non-enhancer of adult brain phenotype of Hsap\APPAβ42.UAS.Tag:SS(rPENK), Scer\GAL4elav-C155
HpdMI12465 heterozygosity enhances the adult locomotion defects, but has no effect on the adult brain loss and vacuolization, induced by the expression of Hsap\APPAβ42.UAS.Tag:SS(rPENK) under the control of Scer\GAL4elav-C155.